A similar chemical library screen aiming to identify drugs that target BRCA2‐deficiency was previously performed (Evers et al, 2010) using Brca2−/− mouse mammary tumour‐derived cell lines and the LO‐PAC®1280 Sigma library of pharmacologically active compounds (Dataset EV1). Here, BRCA2 is linked to breast cancer.